Eisai Co., Ltd. (ESALY): Price and Financial Metrics


Eisai Co., Ltd. (ESALY): $108.27

4.65 (+4.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ESALY Stock Price Chart Interactive Chart >

Price chart for ESALY

ESALY Price/Volume Stats

Current price $108.27 52-week high $129.79
Prev. close $103.62 52-week low $61.95
Day low $108.14 Volume 20,900
Day high $109.27 Avg. volume 28,152
50-day MA $73.48 Dividend yield 0.57%
200-day MA $76.05 Market Cap 32.11B

Eisai Co., Ltd. (ESALY) Company Bio


Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. Eisai Co., Ltd. has a research collaboration agreement with Wren Therapeutics Ltd. for the discovery of small molecules that target synuclein for the potential treatment of synucleinopathies, including Parkinson's disease and dementia with Lewy bodies. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was founded in 1941 and is headquartered in Tokyo, Japan.


ESALY Latest News Stream


Event/Time News Detail
Loading, please wait...

ESALY Latest Social Stream


Loading social stream, please wait...

View Full ESALY Social Stream

ESALY Price Returns

1-mo 67.47%
3-mo 58.18%
6-mo 54.30%
1-year 38.68%
3-year 57.00%
5-year 102.10%
YTD 52.69%
2020 -2.26%
2019 -2.64%
2018 39.20%
2017 -0.54%
2016 -13.63%

ESALY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ESALY Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7568 seconds.